🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Brent K. Hollenbeck

University of Michigan

ORCID: 0000-0003-4840-1260

Also affiliated with Massachusetts General Hospital

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.748Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system

Cancer(2023)10.1002/cncr.34916
Top 27%
0.748DataRank
Top 27%16 citations

David A. Elliott, Gillian Duchesne, Kristian Stensland, Megan E.V. Caram, Christina Chapman +8 more

Papers

Driven by 12 papers — median percentile 73. Top paper: “Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system”.

Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system

Cancer(2023)10.1002/cncr.34916
Top 27%
0.748DataRank
Top 27%16 citations

David A. Elliott, Gillian Duchesne, Kristian Stensland, Megan E.V. Caram, Christina Chapman +8 more

Learning from the “tail end” of de-implementation: the case of chemical castration for localized prostate cancer

Implementation Science Communications(2021)10.1186/s43058-021-00224-8
N/A
0.607DataRank · unranked
24 citations

Jane Forman, Jordan B. Sparks, Tabitha Metreger, Sarah T. Hawley, Megan E.V. Caram +11 more

Understanding differences between high and low volume hospitals for radical prostatectomy

Urologic Oncology: Seminars and Original Investigations(2008)10.1016/j.urolonc.2007.04.001
N/A
0.416DataRank · unranked
15 citations

Stephanie Daignault, David C. Miller, Rodney L. Dunn, Scott Gilbert, Alon Z. Weizer +3 more

Factors affecting Accountable Care Organizations’ decisions to remain in or exit the Medicare Shared Savings Program following Pathways to Success

Health Affairs Scholar(2024)10.1093/haschl/qxad093
N/A
0.241DataRank · unranked
4 citations

Jane Forman, Sitara Murali, Lauren E Gauntlett, Sarah L. Krein, Brent K. Hollenbeck +2 more

Learning From the 'Tail End' of De-implementation: The Case of Chemical Castration for Localized Prostate Cancer

Research Square(2020)10.21203/rs.3.rs-132359/v1
N/A
0DataRank · unranked
1 citations

Jane Forman, Jordan B. Sparks, Tabitha Metreger, Sarah T. Hawley, Megan E.V. Caram +11 more

Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitors

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae155
N/A
0DataRank · unranked
4 citations

Mary Oerline, Samuel R. Kaufman, Christopher Dall, Arnav Srivastava, Megan E.V. Caram +3 more

Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing

Urology Practice(2024)10.1097/upj.0000000000000727
N/A
0DataRank · unranked
2 citations

Marissa A. Solorzano, Jake Quarles, Mallory Luke, Milan Patel, Randy Vince +15 more

Association of Pathways to Success Launch With Quality inBeneficiaries With Traditional Medicare

Health Services Research(2025)10.1111/1475-6773.70024
N/A
0DataRank · unranked
0 citations

Addison Shay, Richard A. Hirth, John M. Hollingsworth, Vahakn B. Shahinian, Brent K. Hollenbeck +1 more

Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial

European Urology(2024)10.1016/j.eururo.2024.09.011
N/A
0DataRank · unranked
8 citations

Stephanie Daignault‐Newton, Daniel E. Spratt, R. Dunn, Udit Singhal, Linda A. Okoth +19 more

Intensity of end‐of‐life care for dual‐eligible beneficiaries with cancer and the impact of delivery system affiliation

Cancer(2021)10.1002/cncr.33874
N/A
0DataRank · unranked
7 citations

Ziwei Zhu, Andrew M. Ryan, Brent K. Hollenbeck, David C. Miller, Lindsey A. Herrel

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy

JNCI Cancer Spectrum(2022)10.1093/jncics/pkac025
N/A
0DataRank · unranked
0 citations

Theresa P. Devasia, Megan E.V. Caram, Christina Chapman, A. Zaslavsky, Todd M. Morgan +8 more

National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer

Urology(2023)10.1016/j.urology.2023.10.018
N/A
0DataRank · unranked
18 citations

Megan E.V. Caram, Daniel J. Herr, Jennifer Burns, Jordan B. Sparks, David A. Elliott +7 more